Centogene B V

The momentum for this stock is not very good. Centogene B V is not very popular among insiders. Centogene B V is a mediocre stock to choose.

News

Centogene receives Nasdaq notice for non-compliance

Seeking Alpha - Healthcare Centogene receives Nasdaq notice for non-compliance...\n more…

Centogene receives delisting notice from Nasdaq

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

CENTOGENE Receives Delisting Notice From Nasdaq

Globe Newswire CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Centogene N.V., the essential life science partner for data-driven answers in rare and neurodegenerative...\n more…

Take Care Before Jumping Onto Centogene N.V. (NASDAQ:CNTG) Even Though It's 36% Cheaper

Simply Wall St The Centogene N.V. ( NASDAQ:CNTG ) share price has fared very poorly over the last month, falling by a substantial 36...\n more…

Centogene publishes ROPAD study data on Parkinson's disease in Brain

CENTOGENE Publication in Brain Journal Reveals 15% of Parkinson's Disease Cases Are Linked to Genetic Factors

Globe Newswire Initial data from largest international Parkinson's disease patient cohort shows approximately 90% of these genetically confirmed patients had variants in the LRRK2 or GBA1 genes, making these...\n more…